Current therapy for undescended testicle. Rationale for treatment between ages four and five

A. M. Smith, J. K. Lattimer, M. Rezvan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Clinical experience suggests that the undescended testis is best maintained in a scrotal position. This provides the best opportunity for realization of any remaining fertility potential and facilitates easier examination for neoplastic evidence with heretofore neglected important psychological considerations, and leads to the conclusion that therapy is best carried out between the 4th and 5th birthdays. The potential psychological impact of the migratory testis similarly warrants gonadotropin therapy between the ages of 4 and 5 yr.

Original languageEnglish (US)
Pages (from-to)2557-2560
Number of pages4
JournalNew York State Journal of Medicine
Volume73
Issue number21
StatePublished - Jan 1 1973

Fingerprint

Testis
Psychology
Cryptorchidism
Gonadotropins
Fertility
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Current therapy for undescended testicle. Rationale for treatment between ages four and five. / Smith, A. M.; Lattimer, J. K.; Rezvan, M.

In: New York State Journal of Medicine, Vol. 73, No. 21, 01.01.1973, p. 2557-2560.

Research output: Contribution to journalArticle

Smith, A. M. ; Lattimer, J. K. ; Rezvan, M. / Current therapy for undescended testicle. Rationale for treatment between ages four and five. In: New York State Journal of Medicine. 1973 ; Vol. 73, No. 21. pp. 2557-2560.
@article{575fdbd60cb8434588a3f66c8557006e,
title = "Current therapy for undescended testicle. Rationale for treatment between ages four and five",
abstract = "Clinical experience suggests that the undescended testis is best maintained in a scrotal position. This provides the best opportunity for realization of any remaining fertility potential and facilitates easier examination for neoplastic evidence with heretofore neglected important psychological considerations, and leads to the conclusion that therapy is best carried out between the 4th and 5th birthdays. The potential psychological impact of the migratory testis similarly warrants gonadotropin therapy between the ages of 4 and 5 yr.",
author = "Smith, {A. M.} and Lattimer, {J. K.} and M. Rezvan",
year = "1973",
month = "1",
day = "1",
language = "English (US)",
volume = "73",
pages = "2557--2560",
journal = "New York State Journal of Medicine",
issn = "0028-7628",
number = "21",

}

TY - JOUR

T1 - Current therapy for undescended testicle. Rationale for treatment between ages four and five

AU - Smith, A. M.

AU - Lattimer, J. K.

AU - Rezvan, M.

PY - 1973/1/1

Y1 - 1973/1/1

N2 - Clinical experience suggests that the undescended testis is best maintained in a scrotal position. This provides the best opportunity for realization of any remaining fertility potential and facilitates easier examination for neoplastic evidence with heretofore neglected important psychological considerations, and leads to the conclusion that therapy is best carried out between the 4th and 5th birthdays. The potential psychological impact of the migratory testis similarly warrants gonadotropin therapy between the ages of 4 and 5 yr.

AB - Clinical experience suggests that the undescended testis is best maintained in a scrotal position. This provides the best opportunity for realization of any remaining fertility potential and facilitates easier examination for neoplastic evidence with heretofore neglected important psychological considerations, and leads to the conclusion that therapy is best carried out between the 4th and 5th birthdays. The potential psychological impact of the migratory testis similarly warrants gonadotropin therapy between the ages of 4 and 5 yr.

UR - http://www.scopus.com/inward/record.url?scp=0015841230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015841230&partnerID=8YFLogxK

M3 - Article

C2 - 4148078

AN - SCOPUS:0015841230

VL - 73

SP - 2557

EP - 2560

JO - New York State Journal of Medicine

JF - New York State Journal of Medicine

SN - 0028-7628

IS - 21

ER -